20-F Filing

COLLPLANT BIOTECHNOLOGIES LTD CIK: 1631487 FY 2019

Filing Information

Form Type	20-F
Accession Number	`0001213900-20-008285`
Period End Date	20191231
Filing Date	20200401
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	clgn-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 39 Cash Flow Statement 101 Stockholders Equity 29

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares, par value	`ParValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares, par value	`ParValuePerShare`	1.50	ILS	Point-in-time
Ordinary shares, shares authorized	`NumberOfOrdinarySharesSharesAuthorized`	30.00M	shares	Point-in-time
Ordinary shares, shares authorized	`NumberOfOrdinarySharesSharesAuthorized`	15.00M	shares	Point-in-time
Ordinary shares, shares authorized	`NumberOfOrdinarySharesSharesAuthorized`	30.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$3.79M	USD	Point-in-time
Ordinary shares, shares issued	`NumberOfOrdinarySharesSharesIssued`	3.81M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalents`	$5.35M	USD	Point-in-time
Ordinary shares, shares issued	`NumberOfOrdinarySharesSharesIssued`	5.67M	shares	Point-in-time
Ordinary shares, shares outstanding	`NumberOfOrdinarySharesSharesOutstanding`	3.81M	shares	Point-in-time
Ordinary shares, shares outstanding	`NumberOfOrdinarySharesSharesOutstanding`	5.67M	shares	Point-in-time
Trade receivables	`TradeReceivables`	$516.00K	USD	Point-in-time
Trade receivables	`TradeReceivables`	$79.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`OtherCurrentReceivables`	$270.00K	USD	Point-in-time
Other accounts receivable and prepaid expenses	`OtherCurrentReceivables`	$334.00K	USD	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	$154.00K	USD	Point-in-time
Restricted deposit	`CurrentAssetsRestrictedDeposit`	$12.00K	USD	Point-in-time
Inventory	`Inventories`	$814.00K	USD	Point-in-time
Inventory	`Inventories`	$888.00K	USD	Point-in-time
Total current assets	`CurrentAssets`	$7.17M	USD	Point-in-time
Total current assets	`CurrentAssets`	$5.04M	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$168.00K	USD	Point-in-time
Restricted deposit	`NoncurrentAssetsRestrictedDeposit`	$155.00K	USD	Point-in-time
Long term receivables	`NoncurrentAssetsLongTermReceivables`	-	USD	Point-in-time
Long term receivables	`NoncurrentAssetsLongTermReceivables`	$18.00K	USD	Point-in-time
Operating lease right-of-use assets	`RightofuseAssets`	$3.21M	USD	Point-in-time
Operating lease right-of-use assets	`RightofuseAssets`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$1.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipment`	$2.33M	USD	Point-in-time
Total non-current assets	`NoncurrentAssets`	$1.58M	USD	Point-in-time
Total non-current assets	`NoncurrentAssets`	$5.71M	USD	Point-in-time
Total assets	`Assets`	$8.75M	USD	Point-in-time
Total assets	`Assets`	$10.75M	USD	Point-in-time
Loan	`LongTermLoanCurrent`	$24.00K	USD	Point-in-time
Loan	`LongTermLoanCurrent`	$22.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$833.00K	USD	Point-in-time
Trade payables	`TradeAndOtherCurrentPayablesToTradeSuppliers`	$622.00K	USD	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$619.00K	USD	Point-in-time
Accrued liabilities and other	`OtherCurrentPayables`	$1.20M	USD	Point-in-time
Operating lease liabilities	`CurrentLeaseLiabilities`	-	USD	Point-in-time
Operating lease liabilities	`CurrentLeaseLiabilities`	$455.00K	USD	Point-in-time
Deferred revenues	`DeferredIncomeClassifiedAsCurrent`	$942.00K	USD	Point-in-time
Deferred revenues	`DeferredIncomeClassifiedAsCurrent`	$970.00K	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$3.46M	USD	Point-in-time
Total current liabilities	`CurrentLiabilities`	$2.23M	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$97.00K	USD	Point-in-time
Derivatives	`NoncurrentDebtInstrumentsIssued`	$68.00K	USD	Point-in-time
Loan	`LongTermLoanNonCurrent`	-	USD	Point-in-time
Loan	`LongTermLoanNonCurrent`	$22.00K	USD	Point-in-time
Operating lease liabilities	`NoncurrentLeaseLiabilities`	-	USD	Point-in-time
Operating lease liabilities	`NoncurrentLeaseLiabilities`	$3.14M	USD	Point-in-time
Deferred revenues	`DeferredIncomeClassifiedAsNoncurrent`	$980.00K	USD	Point-in-time
Deferred revenues	`DeferredIncomeClassifiedAsNoncurrent`	-	USD	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$3.21M	USD	Point-in-time
Total non-current liabilities	`NoncurrentLiabilities`	$1.10M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.33M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.66M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingentLiabilities`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingentLiabilities`	-	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 and 15,000,000 ordinary shares as of December 31, 2019 and December 31, 2018; issued and outstanding: 5,670,829 and 3,814,713 ordinary shares as of December 31, 2019 and December 31, 2018, respectively	`OrdinaryShares`	$2.37M	USD	Point-in-time
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 and 15,000,000 ordinary shares as of December 31, 2019 and December 31, 2018; issued and outstanding: 5,670,829 and 3,814,713 ordinary shares as of December 31, 2019 and December 31, 2018, respectively	`OrdinaryShares`	$1.58M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$60.91M	USD	Point-in-time
Additional paid in capital and warrants	`AdditionalPaidinCapital`	$69.95M	USD	Point-in-time
Currency translation differences	`ReserveOfExchangeDifferencesOnTranslation`	$-969.00K	USD	Point-in-time
Currency translation differences	`ReserveOfExchangeDifferencesOnTranslation`	$-969.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-67.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarnings`	$-56.10M	USD	Point-in-time
Total shareholders equity	`Equity`	$5.42M	USD	Point-in-time
Total shareholders equity	`Equity`	$4.09M	USD	Point-in-time
Total shareholders equity	`Equity`	$1.49M	USD	Point-in-time
Total shareholders equity	`Equity`	$5.17M	USD	Point-in-time
Total liabilities and shareholders equity	`EquityAndLiabilities`	$10.75M	USD	Point-in-time
Total liabilities and shareholders equity	`EquityAndLiabilities`	$8.75M	USD	Point-in-time

Income Statement 39 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenue`	$463.00K	USD	Annual
Revenues	`Revenue`	$5.01M	USD	Annual
Revenues	`Revenue`	$2.32M	USD	Annual
Cost of revenues	`CostOfSales`	$1.66M	USD	Annual
Cost of revenues	`CostOfSales`	$48.00K	USD	Annual
Cost of revenues	`CostOfSales`	$1.88M	USD	Annual
Gross Profit	`GrossProfit`	$415.00K	USD	Annual
Gross Profit	`GrossProfit`	$439.00K	USD	Annual
Gross Profit	`GrossProfit`	$3.35M	USD	Annual
General, administrative and marketing	`SellingGeneralAndAdministrativeExpense`	$3.72M	USD	Annual
General, administrative and marketing	`SellingGeneralAndAdministrativeExpense`	$3.66M	USD	Annual
General, administrative and marketing	`SellingGeneralAndAdministrativeExpense`	$2.47M	USD	Annual
Total operating loss	`ProfitLossFromOperatingActivities`	$-7.63M	USD	Annual
Total operating loss	`ProfitLossFromOperatingActivities`	$-4.25M	USD	Annual
Total operating loss	`ProfitLossFromOperatingActivities`	$-5.96M	USD	Annual
Financial expenses	`FinanceCosts`	$3.30M	USD	Annual
Financial expenses	`FinanceCosts`	$47.00K	USD	Annual
Financial expenses	`FinanceCosts`	$2.18M	USD	Annual
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$176.00K	USD	Annual
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$-47.00K	USD	Annual
Exchange differences	`GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss`	$-230.00K	USD	Annual
Financial expenses, net	`FinanceIncomeCost`	$-3.53M	USD	Annual
Financial expenses, net	`FinanceIncomeCost`	$-94.00K	USD	Annual
Financial expenses, net	`FinanceIncomeCost`	$-2.00M	USD	Annual
Loss for the period	`ProfitLoss`	$-11.16M	USD	Annual
Loss for the period	`ProfitLoss`	$-6.25M	USD	Annual
Loss for the period	`ProfitLoss`	$-6.05M	USD	Annual
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	-	USD	Annual
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	$205.00K	USD	Annual
Currency translation differences	`GainsLossesOnExchangeDifferencesOnTranslationNetOfTax`	$-557.00K	USD	Annual
Total comprehensive loss for the period	`ComprehensiveIncome`	$-11.16M	USD	Annual
Total comprehensive loss for the period	`ComprehensiveIncome`	$-6.81M	USD	Annual
Total comprehensive loss for the period	`ComprehensiveIncome`	$-5.85M	USD	Annual
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$2.27	USD	Annual
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$2.23	USD	Annual
Basic and diluted loss per ordinary share	`BasicAndDilutedEarningsLossPerShare`	$1.43	USD	Annual
Weighted average number of shares outstanding used in computation of basic and diluted	`WeightedAverageShares`	4.99M	shares	Annual
Weighted average number of shares outstanding used in computation of basic and diluted	`WeightedAverageShares`	4.38M	shares	Annual
Weighted average number of shares outstanding used in computation of basic and diluted	`WeightedAverageShares`	2.66M	shares	Annual

Cash Flow Statement 101 line items

Line Item	Tag	Value	Unit	Period
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	$-5.70M	USD	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	$-1.22M	USD	Annual
Net cash used in operations (see Appendix A)	`CashFlowsFromUsedInOperations`	$-4.97M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-5.70M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-4.97M	USD	Annual
Net cash used in operating activities	`CashFlowsFromUsedInOperatingActivities`	$-1.22M	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$1.49M	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$127.00K	USD	Annual
Purchase of property and equipment	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$832.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	-	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	-	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	$30.00K	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-1.46M	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-127.00K	USD	Annual
Net cash used in investing activities	`CashFlowsFromUsedInInvestingActivities`	$-832.00K	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	$5.44M	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	$2.78M	USD	Annual
Proceeds from issuance of shares, warrants and debentures, less issuance expenses	`ProceedsFromIssuingShares`	$8.15M	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	-	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	$1.02M	USD	Annual
Exercise of options and warrants into shares	`ProceedsFromExerciseOfOptions`	$7.00K	USD	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	$58.00K	USD	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	-	USD	Annual
Loan received	`ProceedsFromBorrowingsClassifiedAsFinancingActivities`	-	USD	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	$20.00K	USD	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	-	USD	Annual
Loan paid	`RepaymentsOfBorrowingsClassifiedAsFinancingActivities`	$12.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	$70.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	$17.00K	USD	Annual
Payments made for equipment on financing terms	`RepaymentsOfNoncurrentBorrowings`	$70.00K	USD	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$5.41M	USD	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$2.75M	USD	Annual
Net cash provided by financing activities	`CashFlowsFromUsedInFinancingActivities`	$9.11M	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`IncreaseDecreaseInCashAndCashEquivalents`	$-1.75M	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`IncreaseDecreaseInCashAndCashEquivalents`	$704.00K	USD	Annual
Increase (Decrease) in cash and cash equivalents and restricted deposits	`IncreaseDecreaseInCashAndCashEquivalents`	$4.01M	USD	Annual
Cash and cash equivalents and restricted deposits at the beginning of the year	`RestrictedCashAndCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`RestrictedCashAndCashEquivalents`	$5.66M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`RestrictedCashAndCashEquivalents`	$1.13M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the beginning of the year	`RestrictedCashAndCashEquivalents`	$5.28M	USD	Point-in-time
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$62.00K	USD	Annual
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$139.00K	USD	Annual
Exchange differences on cash and cash equivalents and restricted deposits	`EffectOfExchangeRateChangesOnCashAndCashEquivalents`	$-325.00K	USD	Annual
Cash and cash equivalents and restricted deposits at the end of the year	`RestrictedCashAndCashEquivalents`	$3.97M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`RestrictedCashAndCashEquivalents`	$5.66M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`RestrictedCashAndCashEquivalents`	$1.13M	USD	Point-in-time
Cash and cash equivalents and restricted deposits at the end of the year	`RestrictedCashAndCashEquivalents`	$5.28M	USD	Point-in-time
Loss	`ProfitLoss`	$-11.16M	USD	Annual
Loss	`ProfitLoss`	$-6.25M	USD	Annual
Loss	`ProfitLoss`	$-6.05M	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$342.00K	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$539.00K	USD	Annual
Depreciation and amortization	`AdjustmentsForDepreciationAndAmortisationExpense`	$230.00K	USD	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	$1.12M	USD	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	$1.43M	USD	Annual
Share-based compensation to employees and consultants	`AdjustmentsForSharebasedPayments`	$956.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$28.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-62.00K	USD	Annual
Exchange differences on cash and cash equivalents	`EffectOfExchangeRateChangesOnCashAndCashEquivalent`	$-184.00K	USD	Annual
Financial expenses related to financial instruments	`ChangesInFairValueAndAmortizationOfFinancialInstruments`	$12.00K	USD	Annual
Financial expenses related to financial instruments	`ChangesInFairValueAndAmortizationOfFinancialInstruments`	$3.23M	USD	Annual
Financial expenses related to financial instruments	`ChangesInFairValueAndAmortizationOfFinancialInstruments`	$2.29M	USD	Annual
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	-	USD	Annual
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	$382.00K	USD	Annual
Net change of operating lease accounts	`NetChangeOfOperatingLeaseAccounts`	-	USD	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	$-4.83M	USD	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	$-5.95M	USD	Annual
Total net cash used in operations	`CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital`	$-2.36M	USD	Annual
Decrease (increase) in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$437.00K	USD	Annual
Decrease (increase) in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-38.00K	USD	Annual
Decrease (increase) in trade receivables	`AdjustmentsForDecreaseIncreaseInTradeAccountReceivable`	$-439.00K	USD	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-653.00K	USD	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-74.00K	USD	Annual
Increase in inventory	`AdjustmentsForDecreaseIncreaseInInventories`	$-59.00K	USD	Annual
Decrease in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	$35.00K	USD	Annual
Decrease in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	$220.00K	USD	Annual
Decrease in other receivables (including long-term receivables)	`AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables`	$474.00K	USD	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	$-542.00K	USD	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	$228.00K	USD	Annual
Increase (decrease) in trade payables (including long-term payables)	`AdjustmentForIncreaseInLongTermPayables`	$-112.00K	USD	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$24.00K	USD	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$99.00K	USD	Annual
Increase in accrued liabilities and other payables	`AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables`	$629.00K	USD	Annual
Increase (decrease) in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredTaxLiabilityAsset`	$-2.03M	USD	Annual
Increase (decrease) in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredTaxLiabilityAsset`	-	USD	Annual
Increase (decrease) in deferred revenues (including long term deferred revenues)	`IncreaseDecreaseInDeferredTaxLiabilityAsset`	$1.01M	USD	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	$1.15M	USD	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	$247.00K	USD	Annual
Total changes in operating asset and liability	`AdjustmentsForReconcileProfitLoss`	$-141.00K	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	$-5.70M	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	$-4.97M	USD	Annual
Net cash used in operations	`NetCashUsedInOperationsAdditional`	$-1.22M	USD	Annual
Conversion of debentures to pre-paid warrants	`IssueOfConvertibleInstruments`	-	USD	Annual
Conversion of debentures to pre-paid warrants	`IssueOfConvertibleInstruments`	$3.27M	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinaryShares1`	$68.00K	USD	Annual
Conversion of pre-paid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinaryShares1`	$22.00K	USD	Annual
Obtaining right of use assets in exchange for a lease liability	`ObtainingRightOfUseAssetsInExchangeForLeaseLiability`	$97.00K	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	-	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	$2.02M	USD	Annual
Exercise of anti-dilution derivatives	`ExerciseOfAntidilutionDerivatives`	-	USD	Annual
Classification of warrants from liabilities to equity, net	`ClassificationOfWarrantsFromLiabilitiesToEquity`	$1.33M	USD	Annual

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Ordinary shares and warrants	`IssuanceOfOrdinarySharesAndWarrants`	$180.00K	USD	Annual
Ordinary shares and warrants	`IssuanceOfOrdinarySharesAndWarrants`	$100.00K	USD	Annual
Beginning Balance	`Equity`	$5.42M	USD	Point-in-time
Beginning Balance	`Equity`	$4.09M	USD	Point-in-time
Beginning Balance	`Equity`	$1.49M	USD	Point-in-time
Beginning Balance	`Equity`	$5.17M	USD	Point-in-time
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$2.78M	USD	Annual
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$7.37M	USD	Annual
Issuance of ordinary shares and warrants, net of issuance costs	`IncreaseDecreaseInNumberOfOrdinarySharesIssuedValue`	$7.10M	USD	Annual
Classification of warrants from equity to liability, see note 2c	`IncreaseDecreaseThroughClassificationOfWarrantsFromEquityToLiability`	$-1.80M	USD	Annual
Classification of warrants from liability to equity, see note 8A(2)	`ClassificationOfWarrantsFromLiabilityToEquity`	-	USD	Annual
Classification of warrants from liability to equity, see note 8A(2)	`ClassificationOfWarrantsFromLiabilityToEquity`	$3.14M	USD	Annual
Conversion of debentures to prepaid warrants	`IncreaseDecreaseThroughConversionOfConvertibleInstruments`	$3.27M	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinaryShares`	-	USD	Annual
Conversion of prepaid warrants to ordinary shares	`ConversionOfPrepaidWarrantsToOrdinaryShares`	-	USD	Annual
Exercise of warrants	`IncreaseDecreaseThroughExerciseOfWarrantsEquity`	$1.02M	USD	Annual
Exercise of option	`IncreaseDecreaseThroughExerciseOfOptions`	$7.00K	USD	Annual
Shares issued for services	`IncreaseDecreaseThroughSharesIssuedForServices`	$871.00K	USD	Annual
Shares issued for services	`IncreaseDecreaseThroughSharesIssuedForServices`	$8.00K	USD	Annual
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$1.00M	USD	Annual
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$531.00K	USD	Annual
Share-based compensation	`IncreaseDecreaseThroughSharebasedPaymentTransactions`	$1.12M	USD	Annual
Comprehensive loss	`ComprehensiveIncome`	$-11.16M	USD	Annual
Comprehensive loss	`ComprehensiveIncome`	$-6.81M	USD	Annual
Comprehensive loss	`ComprehensiveIncome`	$-5.85M	USD	Annual
Ending Balance at Dec. 31, 2017	`Equity`	$5.42M	USD	Point-in-time
Ending Balance at Dec. 31, 2017	`Equity`	$4.09M	USD	Point-in-time
Ending Balance at Dec. 31, 2017	`Equity`	$1.49M	USD	Point-in-time
Ending Balance at Dec. 31, 2017	`Equity`	$5.17M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.